We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
The current HAE market cap is 4.34B. The company's latest EPS is USD 2.3148 and P/E is 36.89.
| Quarter End | Apr 2023 | Jul 2023 | Sep 2023 | Dec 2023 | Mar 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 304.42M | 311.33M | 318.18M | 336.25M | 343.29M |
| Operating Income | 35.26M | 53.66M | 35.3M | 45.98M | 27.94M |
| Net Income | 29.38M | 41.04M | 24.91M | 31.24M | 20.37M |
| Year End 30 March 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 988.48M | 903.28M | 1B | 1.17B | 1.31B |
| Operating Income | 153.95M | 90.78M | 81.33M | 155.65M | 162.88M |
| Net Income | 76.53M | 79.47M | 43.38M | 115.4M | 117.56M |
| Quarter End | Apr 2023 | Jul 2023 | Sep 2023 | Dec 2023 | Mar 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 1.93B | 1.96B | 2.01B | 2.2B | 2.2B |
| Total Liabilities | 1.12B | 1.1B | 1.12B | 1.26B | 1.24B |
| Total Equity | 818M | 864.62M | 893.66M | 943.32M | 959.96M |
| Year End 30 March 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 1.27B | 1.82B | 1.86B | 1.93B | 2.2B |
| Total Liabilities | 680M | 1.09B | 1.11B | 1.12B | 1.24B |
| Total Equity | 587.11M | 731.67M | 749.42M | 818M | 959.96M |
| Quarter End | Apr 2023 | Jul 2023 | Sep 2023 | Dec 2023 | Mar 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | 273.06M | 19.09M | 118.21M | 117.67M | 181.75M |
| Investing | -143.79M | -15.26M | -40.4M | -309.33M | -322.39M |
| Financing | -100.36M | -598k | -7.77M | 101.66M | 38.16M |
| Year End 30 March 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | 158.22M | 108.81M | 172.26M | 273.06M | 181.75M |
| Investing | -57.18M | -425.44M | -86.35M | -143.79M | -322.39M |
| Financing | -131.21M | 367.45M | -15.75M | -100.36M | 38.16M |
| Market Cap | 4.34B |
| Price to Earnings Ratio | 36.89 |
| Price to Sales Ratio | 3.31 |
| Price to Cash Ratio | 24.25 |
| Price to Book Ratio | 4.52 |
| Dividend Yield | - |
| Shares Outstanding | 50.79M |
| Average Volume (1 week) | 600.98k |
| Average Volume (1 Month) | 787.69k |
| 52 Week Change | 1.53% |
| 52 Week High | 97.97 |
| 52 Week Low | 70.74 |
| Spread (Intraday) | 32.93 (28.15%) |
| Company Name | Haemonetics Corp |
| Address |
155 federal street boston, massachusetts 02110 |
| Website | https://www.haemonetics.com |
| Industry | surgical,med instr,apparatus (3841) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
